At our hospital, when taking into account all the cases diagnosed as RTT that have a mutation in MECP2, 4.5% of them have large rearrangements (Vidal et al., 2017), which is consistent with what has been reported in the literature (Hardwick et al., 2007). This evidence concerns the gene MECP2 and Rett syndrome.